NASDAQ:EYEG
Delisted
Eyegate Pharmaceuticals Stock News
$0.141
-0.0080 (-5.37%)
At Close: Aug 17, 2022
EYEG Stock Price: Why It Substantially Increased
05:19am, Friday, 01'st Oct 2021
The stock price of Eyegate Pharmaceuticals Inc (NASDAQ: EYEG) increased 22.95% in the previous trading session. This is why it happened.
7 Best Penny Stocks to Buy on the Nasdaq for October
10:20am, Wednesday, 29'th Sep 2021
Penny stocks have a place in every portfolio when adjusted for risk. These 7 have the added safety of a Nasdaq listing.
Best Penny Stocks to Buy Right Now? 3 to Watch in October
01:55pm, Friday, 24'th Sep 2021
Investing in penny stocks in 2021? Check these three out for next months watchlist The post Best Penny Stocks to Buy Right Now?
Penny Stocks For Your Biotech Watch List In September 2021
11:04am, Wednesday, 15'th Sep 2021
Penny stocks that may be worth watching right now. The post Penny Stocks For Your Biotech Watch List In September 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.
4 Penny Stocks To Buy According To Analysts & Price Targets Up To 507%
12:21pm, Tuesday, 14'th Sep 2021
Biotech Penny Stocks Surge As Sector Reverses Course The post 4 Penny Stocks To Buy According To Analysts & Price Targets Up To 507% appeared first on Penny Stocks to Buy, Picks, News and Information
EyeGate to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
04:15pm, Thursday, 09'th Sep 2021
WALTHAM, Mass., Sept. 09, 2021 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG), (“EyeGate” or the “Company”), a clinical-stage specialty pharmaceutical company developing and
-Proof-of-concept study conducted in Austria; Study designed to build upon positive Phase 1 safety data in healthy volunteers-
Top Penny Stocks You Need to Know About Right Now
01:00pm, Friday, 20'th Aug 2021
Are these top penny stocks on your small-caps watchlist The post Top Penny Stocks You Need to Know About Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
EyeGate Pharma Reports Second Quarter 2021 Financial Results and Provides Business Update
04:15pm, Thursday, 12'th Aug 2021
WALTHAM, Mass., Aug. 12, 2021 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG), (“EyeGate” or the “Company”), a clinical-stage company developing and commercializing products f
EYEG Stock Price Falls Over 14% Pre-Market: Why It Happened
07:36am, Tuesday, 10'th Aug 2021
The stock price of Eyegate Pharmaceuticals Inc (NASDAQ: EYEG) fell by over 14% pre-market. This is why it happened.
EyeGate Announces $10.75 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
06:55am, Tuesday, 10'th Aug 2021
WALTHAM, Mass., Aug. 10, 2021 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or the “Company”), a clinical-stage company developing and commercializing products fo
EYEG Stock Increases Over 135% Pre-Market: Why It Happened
07:54am, Tuesday, 27'th Jul 2021
The stock price of Eyegate Pharmaceuticals Inc (NASDAQ: EYEG) increased by over 135% pre-market. This is why it happened.
Why Shares Of Eyegate Pharmaceuticals Spiked After Hours Monday
05:20pm, Monday, 26'th Jul 2021
Eyegate Pharmaceuticals (NASDAQ: EYEG) shares are trading higher Monday afternoon after the company announced it entered a non-binding letter of intent to acquire Bayon Therapeutics for roughly $7.1
EyeGate Pharmaceuticals Announces Appointment of Brian M. Strem, Ph.D.
04:15pm, Monday, 26'th Jul 2021
-EyeGate signs non-binding letter of intent to acquire Bayon Therapeutics, a private ophthalmic pharmaceutical company developing a novel, vision restoring small molecule platform- -EyeGate signs non-
EyeGate Pharma Announces First Patient Dosed for PP-001 in a Phase 2 Proof-of-Concept Ocular Surface Inflammation Study
06:55am, Monday, 14'th Jun 2021
- Proof-of-concept study conducted in Austria- -Topline data expected in Q4 2021-
